Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Hypofractionated radiotherapy to the pancreas: U.K. experience.
Authors
Suliana Teoh
University of Oxford, Oxford, United Kingdom
Suliana Teoh , Ahmad Sabbagh , Jonathan Wadsley , Lori Low , Claire Harrison , Jolyne O'Hare , Rebecca Goody , Kitty Summers , David Wilson , Julie Walther , Fiona Wilson , Ganesh Radhakrishna , Katharine Aitken , Rob Owens , Somnath Mukherjee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Impact of COVID-19
DOI
10.1200/JCO.2022.40.4_suppl.525
Abstract #
525
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Sequential treatment with gemcitabine/nab-paclitaxel (GA) and FOLFIRINOX (FFX) followed by stereotactic MRI-guided adaptive radiation therapy (SMART) in patients with locally advanced pancreatic cancer (LAPC): GABRINOX-ART phase 2, multicenter trial.
First Author: Fabienne Portales
Poster
2022 ASCO Genitourinary Cancers Symposium
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.
First Author: David James Carpenter
Poster
2019 ASCO Annual Meeting
IMRT pelvic radiotherapy with simultaneous integrated boost in high-risk prostate cancer: Results after 10 years.
First Author: Christian Ekanger
Poster
2018 ASCO Annual Meeting
Limited stage nodular lymphocyte predominant Hodgkin lymphoma (NLPHL): A subgroup analysis of the HD.6 clinical trial.
First Author: Bethany Monteith